Literature DB >> 27844163

Isolated recurrent myelitis in a 7-year-old child with serum aquaporin-4 IgG antibodies.

Andrea Bianchi1, Emanuele Bartolini2, Federico Melani2, Renzo Guerrini2, Mario Mascalchi3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27844163     DOI： 10.1007/s00415-016-8332-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

Review 1.  The differential diagnosis of longitudinally extensive transverse myelitis.

Authors:  J L Kitley; M I Leite; J S George; J A Palace
Journal:  Mult Scler       Date:  2011-06-13       Impact factor: 6.312

Review 2.  Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents.

Authors:  Silvia N Tenembaum
Journal:  Clin Neurol Neurosurg       Date:  2013-12       Impact factor: 1.876

3.  CNS aquaporin-4 autoimmunity in children.

Authors:  A McKeon; V A Lennon; T Lotze; S Tenenbaum; J M Ness; M Rensel; N L Kuntz; J P Fryer; H Homburger; J Hunter; B G Weinshenker; K Krecke; C F Lucchinetti; S J Pittock
Journal:  Neurology       Date:  2008-05-28       Impact factor: 9.910

Review 4.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

Review 5.  Conventional and advanced imaging in neuromyelitis optica.

Authors:  Y Barnett; I J Sutton; M Ghadiri; L Masters; R Zivadinov; M H Barnett
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

6.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

7.  Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.

Authors:  Giulia Longoni; Brenda Banwell; Massimo Filippi; E Ann Yeh
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-12-11

Review 8.  Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis.

Authors:  Valentina Damato; Amelia Evoli; Raffaele Iorio
Journal:  JAMA Neurol       Date:  2016-11-01       Impact factor: 18.302

9.  Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.

Authors:  Margherita Nosadini; Gulay Alper; Catherine J Riney; Leslie A Benson; Shekeeb S Mohammad; Sudarshini Ramanathan; Melinda Nolan; Richard Appleton; Richard J Leventer; Kumaran Deiva; Fabienne Brilot; Mark P Gorman; Amy T Waldman; Brenda Banwell; Russell C Dale
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-01-21
  9 in total
  1 in total

Review 1.  Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review.

Authors:  Michela Ada Noris Ferilli; Roberto Paparella; Ilaria Morandini; Laura Papetti; Lorenzo Figà Talamanca; Claudia Ruscitto; Fabiana Ursitti; Romina Moavero; Giorgia Sforza; Samuela Tarantino; Martina Proietti Checchi; Federico Vigevano; Massimiliano Valeriani
Journal:  Life (Basel)       Date:  2021-12-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.